SCHEMBL2201803

SCHEMBL2201803

O=[C]C(F)(F)C(F)(F)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11368310 0.82
SCHEMBL137007 0.82
SCHEMBL5965396 0.82
SCHEMBL5965345 0.79
SCHEMBL11525767 0.79
SCHEMBL3823812 0.76
SCHEMBL4196957 0.76
SCHEMBL8011426 0.76
SCHEMBL514546 0.76
SCHEMBL2466 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977420-B2 Reactive material compositions, shot shells including reactive materials, and a method of producing same ALLIANT TECHSYSTEMS INC. (US) 2011-07-12 US claimed
US-20070272112-A1 REACTIVE MATERIAL COMPOSITIONS, SHOT SHELLS INCLUDING REACTIVE MATERIALS, AND A METHOD OF PRODUCING SAME ALLIANT TECHSYSTEMS INC. (US) 2007-11-29 US claimed
JP-9188648-A None JP disclosed
CN-116064468-B Chemically modified Taq enzyme storage solution 南京诺唯赞生物科技股份有限公司 2023-11-21 CN disclosed
CN-116064468-A Chemically modified Taq enzyme storage solution 南京诺唯赞生物科技股份有限公司 2023-05-05 CN disclosed
CN-110770200-B Process for preparing polyfluorinated allyl ethers and compounds related thereto 3M创新有限公司 2022-10-04 CN disclosed
CN-110088168-B (per) fluoropolyether polymers 索尔维特殊聚合物意大利有限公司 2022-07-19 CN disclosed
US-9683821-B2 Reactive material enhanced projectiles, devices for generating reactive material enhanced projectiles and related methods ORBITAL ATK, INC. (US) 2017-06-20 US disclosed
US-20160209187-A1 REACTIVE MATERIAL ENHANCED PROJECTILES, DEVICES FOR GENERATING REACTIVE MATERIAL ENHANCED PROJECTILES AND RELATED METHODS NORTHROP GRUMMAN SYSTEMS CORPORATION 2016-07-21 US disclosed
US-8443731-B1 Reactive material enhanced projectiles, devices for generating reactive material enhanced projectiles and related methods ALLIANT TECHSYSTEMS INC. (US) 2013-05-21 US disclosed
US-20130104765-A1 REACTIVE MATERIAL ENHANCED PROJECTILES, DEVICES FOR GENERATING REACTIVE MATERIAL ENHANCED PROJECTILES AND RELATED METHODS NORTHROP GRUMMAN SYSTEMS CORPORATION 2013-05-02 US disclosed
US-5208312-A Release agents DOW CORNING CORPORATION (US) 1993-05-04 US disclosed
EP-0520608-A1 Silicones which contain lateral peripheral vinyl ether groups crosslinkable by cationic photoinitiators and their application for coatings and antiadhesive products for paper DOW CORNING CORPORATION (US) 1992-12-30 EP disclosed
US-5106955-A Reversibly modifying an antibody which decreases its immunoactivity; reacting with a drug, hormone or enzyme; removing the modifier to restore completely the original immunoactivity TEIJIN LIMITED (JP) 1992-04-21 US disclosed
US-5093531-A POLYETHYLENE GLYCOL SUBSTITUTED PHENYL GLYOXALS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1992-03-03 US disclosed
US-5041588-A Telomers of cotelomers of fluoroolefins or fluorinated oxetanes or oxiranes; seals, elastomers, release agents, coatings DOW CORNING CORPORATION (US) 1991-08-20 US disclosed
EP-0400486-A2 Polyethylene glycol derivatives, modified peptides and production thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1990-12-05 EP disclosed
EP-0340741-A2 Polyethylene glycol derivatives, modified peptides and production thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1989-11-08 EP disclosed
EP-0307480-A1 PROCESS FOR PREPARING ANTIBODY COMPLEX TEIJIN LIMITED (JP) 1989-03-22 EP disclosed
US-4153687-A Derivatives, having an inhibitory action against protease and an antiphlogistic action, of the trypsin-kallikrein inhibitor obtained from cattle organs (BPTI), their preparation and their use as medicaments BAYER AKTIENGESELLSCHAFT (DE) 1979-05-08 US disclosed